证券代码：839273 证券简称：一致魔芋 公告编号：2024-102 湖北一致魔芋生物科技股份有限公司 2024 年股权激励计划限制性股票首次授予结果公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、限制性股票首次授予结果 （一）实际授予基本情况 6、股票来源：公司回购专用账户所持有的本公司 A 股普通股股票 （二）实际首次授予登记的限制性股票在各激励对象间的分配情况 | 姓名 | 职务 | 获授的限制性股 | 占授予限制性股 | 占目前股本总 | | --- | --- | --- | --- | --- | | | | 票数量（股） | 票总量的比例% | 额的比例% | | 吴 平 | 董事长、总经理 | 150,000 | 8.33 | 0.20 | | 彭 湃 | 董事、副总经理 | 79,000 | 4.39 | 0.11 | | 李 夏 | 副总经理 | 63,400 | 3.52 | 0.09 | | 苟春鹏 | 董事、副总经理 | 79,000 | 4.39 | 0.11 | ...

证券代码：839273 证券简称：一致魔芋 公告编号：2024-101 湖北一致魔芋生物科技股份有限公司 关于变更项目合伙人及签字注册会计师的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 湖北一致魔芋生物科技股份有限公司（以下简称"公司"）于 2024 年 3 月 20 日召开了第三届董事会第十二次会议、第三届监事会第十次会议，审议通过了 《关于续聘 2024 年度审计机构的议案》，同意公司续聘中汇会计师事务所（特 殊普通合伙）（以下简称"中汇"）担任公司 2024 年度审计机构，上述议案已 于 2024 年 4 月 12 日召开的 2023 年年度股东大会审议通过。 2024 年 11 月 14 日，公司收到中汇出具的《关于变更签字会计师的告知函》， 现将具体情况公告如下： 一、本次变更签字注册会计师的基本情况 中汇作为公司 2024 年度审计机构，原委派洪烨先生、徐庆平先生作为公司 2024 年度财务报表审计报告和内部控制审计报告的签字注册会计师。因内部工作 调整，现委派卿武勤先生接替洪烨先 ...

Group 1: Investor Relations Activity - The investor relations activity took place from November 9 to November 12, 2024, at the company's conference room in Hubei [2] - Attendees included representatives from Haitong Securities and CITIC Securities, with the company represented by the Chairwoman and General Manager Wu Ping and Secretary of the Board Tang Hualin [2] Group 2: Product Sourcing and Production Capacity - The company sources raw materials primarily from the Yunnan-Guizhou Plateau, Wuling Mountain area, and Qinba Mountain range, with some imports from Southeast Asia, ensuring sufficient production capacity [2][3] Group 3: Research and Development Initiatives - The company emphasizes R&D through a combination of independent and collaborative efforts, focusing on the unique properties of konjac to enhance product variety [3] - It has developed various konjac gum products based on rheological properties, providing application solutions to clients [3] - Collaboration with academic teams for foundational research on konjac glucomannan's effects on lowering blood lipids and blood sugar [3] Group 4: Technological Advantages - The company holds a total of 85 patents, including 27 invention patents and 47 utility model patents, contributing to its competitive edge [4] - It plays a significant role in drafting industry standards for konjac products, enhancing its market position [4] Group 5: Financial Performance - In Q3 2024, the company reported a revenue of CNY 174 million and a net profit of CNY 28.08 million, driven by strong sales of konjac food and powder [5] - Year-to-date revenue reached CNY 436 million, a 19.30% increase year-on-year, with net profit up 65.17% to CNY 57.51 million [5] - Sales of konjac food increased by 61.66%, with konjac snacks growing by 166.77% and konjac balls by 46.37% [5] Group 6: Cash Flow and Sustainability - A significant decrease in net cash flow from operating activities was noted due to early harvesting and increased raw material purchases, alongside rising prices of konjac powder [5] - The company aims to sustain growth by transforming into a konjac powder application service provider and expanding production capacity through new projects [6] Group 7: Strategic Partnerships and Market Expansion - The company is exploring partnerships with major retail chains for customized products, recognizing successful collaboration models in the industry [6] - Future strategies include providing safe and natural konjac applications globally, focusing on three main product categories: konjac hydrophilic colloids, konjac food, and konjac cosmetics [7] Group 8: Market Position and Future Directions - The company is the global leader in konjac powder sales from April 2023 to April 2024, according to Frost & Sullivan [7] - The five-year strategic direction emphasizes expanding applications in jelly, meat products, tea ingredients, and konjac food [7]

证券代码：839273 证券简称:一致魔芋 公告编号：2024-098 （1）前期公告的事项是否取得重大进展或变化，前期披露的公告是否需要更正、补充； （2）是否存在可能或已经对本公司股票交易价格产生较大影响的媒体报道或市场传闻， 是否涉及热点概念事项； （3）近期公司经营情况及内外部经营环境是否或预计将要发生重大变化； （4）公司、控股股东和实际控制人是否存在关于本公司的应披露而未披露的重大事项， 或处于筹划阶段的重大事项； 湖北一致魔芋生物科技股份有限公司股票交易异常波动公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、股票交易异常波动的具体情况 公司股票最近 2 个有成交的交易日（2024 年 10 月 28 日至 2024 年 10 月 29 日）以内收 盘价涨幅偏离值累计达到 50.85%，根据《北京证券交易所交易规则（试行）》的有关规定， 属于股票交易异常波动情形。 二、公司关注并核实的相关情况 1、 关注问题： 四、公司及控股股东、实际控制人、董监高在异常波动期间交易公司股票的情况 ...

| | 公告日期 2024-10-29 | 异常期间 | 2024-10-29 | | | | | --- | --- | --- | --- | --- | --- | --- | | | 一致魔芋(839273) 连续竞价 | 成交数量 （股） | 13186535.0 | 成交金额（万 元） | 27451.28 | | | | 北交所股票最近3个有成交的交易日以内收盘价涨跌幅偏离值累计达到+40% 涉及事项 | | | | | | | | (-40%) | | | | | | | 买/卖 | 营业部或交易单元名称 | | | 买入金额（元） | 卖出金额（元） | | | 买1 | 中信建投证券股份有限公司泰州海陵南路证券营业部 | | | 6364350.08 | | 14276.74 | | 买2 | 东方财富证券股份有限公司拉萨东环路第一证券营业部 | | | 4642545.45 | | 2692864.21 | | 买3 | 东吴证券股份有限公司苏州西北街二部营业部 | | | 4348705.42 | | 4073532.22 | | 买4 | 中信证券股份有限公司义乌城中中路证券营业部 ...

| 日期 | 代码 | 简称 | 成交数量（股） | 成交金额（万元） | 披露原因 | | --- | --- | --- | --- | --- | --- | | 2024-10- | 832145 | 恒合股份 | 14914315.0 | 17317.78 | 异常期间涨跌幅偏离值累计 | | 29 | | | | | 达到64.32% | | 2024-10- | 832802 | 保丽洁 | 14805601.0 | 29881.96 | 异常期间涨跌幅偏离值累计 | | 29 | | | | | 达到64.31% | | 2024-10- | 831856 | 浩淼科技 | 26385668.0 | 27078.24 | 异常期间涨跌幅偏离值累计 | | 29 | | | | | 达到64.24% | | 2024-10- 29 | 830964 | 润农节水 | 5221223 | 3431.3 | 异常期间涨跌幅偏离值累计 达到64.13% | | 2024-10- | | | | | 异常期间涨跌幅偏离值累计 | | 29 | 872392 | 佳合科技 | 15804573.0 | 3 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][3] Core Views - The company achieved a revenue of 436 million yuan in Q1-Q3 2024, representing a year-on-year increase of 19.3%, and a net profit attributable to shareholders of 62.06 million yuan, up 15.5% year-on-year. The non-recurring net profit saw a significant increase of 65.2% [3] - The company is transitioning from a raw material manufacturer to an application service provider, focusing on technological research and development to provide solutions and products for clients. The strategic direction for the next five years includes expanding applications in konjac powder and downstream product processing, particularly in jelly, meat products, tea drink ingredients, and konjac food [4] - The company is actively expanding its customer base, with stable orders from leading enterprises such as Mixue Ice City and Hou Shang Ayi, while also targeting second-tier brand clients. The production capacity is being increased to meet market demand, with a current full-load operation of production lines [5] Financial Summary - For the fiscal years 2022 to 2026, the company forecasts revenue growth from 447 million yuan in 2022 to 688 million yuan in 2026, with corresponding net profits expected to rise from 65 million yuan to 79 million yuan. The projected EPS for these years is 0.89, 0.72, 0.88, 0.97, and 1.07 yuan per share respectively [6][8] - The gross margin is expected to improve slightly from 21.0% in 2023 to 21.9% in 2024, while the net margin is projected to stabilize around 11.5% by 2026 [6][9]

Group 1 - The core viewpoint of the article indicates that the overall decline in the basic chemical industry is 0.28%, with 186 stocks experiencing price increases and 3 stocks, including Yabong Co. and Yayun Co., hitting the daily limit up [1] - Among the stocks that declined, Hanwei Technology, Meibang Technology, and Beihua Co. had significant drops of 10.00%, 8.96%, and 7.75% respectively [1] - The latest margin trading data shows that the margin balance for the stock as of October 25 is 961,100 yuan, with a financing balance of 961,100 yuan, reflecting a decrease of 225,400 yuan over the past 10 days, which is a 19.00% decline [1]

证券代码：839273 证券简称：一致魔芋 公告编号：2024-095 湖北一致魔芋生物科技股份有限公司 关于拟注销控股子公司的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 湖北一致魔芋生物科技股份有限公司（以下简称"公司"）于 2024 年 10 月 24 日召开了第三届董事会第十八次会议、第三届监事会第十七次会议，审议通过 了《关于拟注销控股子公司的议案》。根据公司章程及相关法律法规规定，本议 案无须提交股东大会审议。现将具体情况公告如下： 一、拟注销控股子公司的基本情况 住所：中国(湖北)自贸区宜昌片区生物产业园花溪路 188 号跨境电商产业园 0415 经营范围：生物制品研制、开发、销售；母婴用品、纸尿裤、化妆品、纸制 日用百货的批发、零售；货物进出口贸易（法律、行政法规禁止、限制以及指定 经营的进出口项目除外)；电子商务信息咨询；企业形象策划；会务服务；展览 展示服务；市场调研（服务类，不含社会及民意调查）（依法须经批准的项目， 经相关部门批准后方可开展经营活动） 股东结构：公司持有 ...

证券代码：839273 证券简称：一致魔芋 公告编号：2024-096 湖北一致魔芋生物科技股份有限公司 关于调整公司组织架构的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 湖北一致魔芋生物科技股份有限公司（以下简称"公司"）于 2024 年 10 月 24 日召开了第三届董事会第十八次会议，审议通过了《关于调整公司组织架构的 议案》。根据公司章程及相关法律法规规定，本议案无须提交股东大会审议。现 将具体情况公告如下： 一、公司组织架构调整的情况 股子公司湖北致心生物科技有限公司在完成注销程序后，即从公司组织架构中删 除，公司组织架构不再另行公告。 二、组织架构调整对公司的影响 本次组织架构的调整结合了公司实际发展情况，明晰并强化了各部门的职责 工作，有利于进一步提高组织运营效率。公司的经营主体、经营业务以及人员未 发生重大实质变化，不会影响公司的正常经营，亦不会损害公司及股东的利益。 三、备查文件 1、《湖北一致魔芋生物科技股份有限公司第三届董事会第十八次会议决 议》； 湖北一致魔芋生物科技股 ...